U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369180) titled 'NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol' on Jan. 24.
Brief Summary: Transcranial Magnetic Stimulation (TMS) Therapy is a non-invasive procedure that uses magnetic pulses to stimulate the cortex (brain) to treat Major Depressive Disorder (MDD). Currently established therapy uses one 19-minute treatment session per day for 5 days per week for 6 weeks, for a total of 30 treatment sessions.
The goal of this multi-site sham-controlled double-blinded randomized clinical trial is to evaluate the safety and effectiveness of accelerating the delivery of the NeuroQore Square TMS system's rectangular waveform rT...